Diabetes management, if limited to FDA recommendations is largely ineffective.
We've all heard about the "Keto Diet", but is it good for people with type 1 and type 2 diabetes? Get an unbiased breakdown from 2 Certified Diabetes Educators.
Have there been any documented deaths from waiting too long on hold with an insurance company? I may have come close a few times. The hold times can be anywhere from a lucky few minutes to my all-time record of 37 minutes. Speaking of, I am currently in minute 23 as I type.
Medtronic’s Hybrid Closed Loop System: Getting More Bang For Your Buck By, Gary Scheiner MS, CDE, Jennifer Smith RD, LD, CDE, Alicia Downs RN, MSN, CDE, Annette Valle RN, [...]
A recent study showed that the insulin users in North America make up 14% of all insulin users worldwide, but they account for nearly 50% of total world-wide sales. With so many profit-making avenues, you can see why this three-company oligopoly (Lilly, Novo Nordisk, Sanofi) is keen to keep raising insulin prices.
My dad is a mechanic, so I spent my formative years leaning over engines and climbing on car lifts getting covered in grease stains and rust. So it's probably no [...]
As usual, this year’s American Diabetes Association Scientific Sessions didn’t place much emphasis on a healthy lifestyle. There was food everywhere, and trust me, we’re not talking fruits & veggies. But there was a great deal of research presented on diabetes medications and devices.
One of the best examples I’ve come across in the “regulation vs. right to choose” debate related to diabetes technology is the We Are Not Waiting movement within the diabetes space.
There is no doubt that CGM can improve the quality of life and blood sugar control for just about everyone with diabetes. But which system is best for you?
IDS Clinicians Offer Different Perspectives on the Medtronic 670G after 10 days of use. Read what they have to say...
Diabetes educator, Gary Scheiner gives his in-depth review of the newly approved Abbott Freestyle Libre CGM continuous glucose monitor.
The 670G represents an important step towards fully automating glucose control. However, it is important to put it in the proper context and set expectations at an appropriate level.
The National Diabetes Statistics Report from the Centers for Disease Control and Prevention shows that 29 million Americans have diabetes, and 95 percent of them have Type 2, the form [...]
It's awesome that people with diabetes are living normal lifespans, but the current Medicare system is not set up to provide coverage of the technologies that we become accustomed to using when we have commercial insurance coverage to control the disease as well as we can.
Meters should be within 10% of lab values to be considered accurate. The more often a meter falls within 10% (or 10 points) of the lab value, the more reliable it will be.